The STEMI Pharmaco-Invasive Therapy in Africa: Bridging the Gap
Emmanuel Auchi Edafe, Maclean Romokere Akpa, Muhammad Nazir Shehu.
Introduction: The pharmaco-invasive therapy, refers to the technique whereby there is a time elapse of 3-24 hours between thrombolysis (pharmaco) and PCI (invasive) when using fibrin specific thrombolytic agents. The aim of this study was to evaluate 74 patients with STEMI over 5-year period who were treatment with pharmaco-invasive therapy in 3 PCI centers in Nigeria.
Methods: This was a retrospective observational study. Three cardiac catheterization laboratories cases were searched. These cardiac catheterization laboratories included Bayelsa specialist Hospital, Yenagoa, Cardiocare Multispecialty Hospital, Abuja and Save a Life Mission Hospital, Port Harcourt, Rivers. These cases of pharmacoinvasive therapy from 1st of January 2018 to 28th February, 2023 were included. The data analysis was done with SPSS version
Results: There were 74 patients who had STEMI and underwent pharmacoinvasive therapy for the period. There were 38 males. The mean age of STEMI for both men and women 62.5 ± 12.6.The drugs used were Streptokinase, Alteplase and Tenecteplase.
View pdf